Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-25

Clinical Trial Update: Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Omiganan 1% Gel to chlorhexidine 2% for topical skin antisepsis in healthy adults; results were completed and posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine 2% (chlorhexidine)
  • Omiganan 1% Gel (omiganan)

Snippet

Sponsor: Cadence Pharmaceuticals | Conditions: Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-01-25